Co-expression of DKK-1 and Sclerostin in Subchondral Bone of the Proximal Femoral Heads from Osteoarthritic Hips by Allahdad Zarei et al.
Vol.:(0123456789) 
Calcif Tissue Int 
DOI 10.1007/s00223-017-0246-7
ORIGINAL RESEARCH
Co-expression of DKK-1 and Sclerostin in Subchondral Bone 
of the Proximal Femoral Heads from Osteoarthritic Hips
Allahdad Zarei1 · Philippa A. Hulley1 · Afsie Sabokbar1 · M. Kassim Javaid1  
Received: 6 October 2016 / Accepted: 30 January 2017 
© The Author(s) 2017. This article is published with open access at Springerlink.com
Expression was highest in the osteocytes in bone under-
lying partial thickness cartilage defects. It is however not 
clear if this is a cause or a consequence of alterations in the 
overlying cartilage. However, it is suggestive of an active 
remodeling process which might be targeted by disease-
modifying agents.
Keywords Osteoarthritis · Subchondral bone · DKK-1 · 
SOST · Wnt
Background
There is a growing body of evidence demonstrating changes 
in the architecture in subchondral bone underlying OA car-
tilage lesions, which may contribute to the pathogenesis of 
both structural and symptomatic features of OA [1]. The 
principal role of the subchondral bone is mechanical with 
the cortical and trabecular bone compartments continually 
responding to loads applied to them by remodeling, via the 
osteocyte network and Wnt signaling [2–4]. The resulting 
changes in the mechanical properties of the subchondral 
plate determine, in part, the load exposure of the cartilage 
at the joint surface leading to a dynamic interplay between 
loading and bone structure [5].
OA is a disease involving cartilage damage, changes in 
underlying subchondral bone, osteophyte formation, and 
inflammation of the joint with unknown factors that initiate 
these changes [6]. Our current knowledge of the factors that 
may be involved in the progression of OA includes weight 
bearing with aging, increased loading from obesity, and 
previous injuries [7, 8]. The search for other factors that 
may be involved in cartilage degradation accompanied by 
alterations in underlying bone has introduced new direc-
tions for investigations focused on signaling pathways such 
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as Wnt-frizzled pathways and associated protein regulators. 
The Wnt-β-catenin pathway is involved during embryogen-
esis of the joint and skeletal homeostasis during adulthood 
[9–11]. The Wnt signaling pathway is known to be associ-
ated with responses to mechanical degradation in cartilage 
[12]. Normally in the absence of extracellular signals, cyto-
plasmic β-catenin is bound to oligomeric complexes that 
facilitate β-catenin phosphorylation and consequently its 
proteolytic degradation [13]. In the presence of extracellu-
lar ligands unphosphorylated β-catenin accumulates in the 
cell cytoplasm and then translocates into the nucleus, bind-
ing to transcription factors that activate target signals [14].
Regulation of the Wnt pathway involves natural extracel-
lular inhibitors such as DKK-1 and SOST [15, 16]. Muta-
tions that augment the Wnt signaling pathway and stop its 
interaction with DKK-1 have been shown to be associated 
with an increase in bone mass density in human adults [17]. 
Loss of function and mutation of the SOST gene is associ-
ated with sclerosteosis and Van Buchem disease with a pro-
gressive bone growth and high bone mineral density [18].
Differential expression of Wnt proteins and Wnt inhibi-
tors has been shown in OA, and excessive Wnt signaling 
has also been thought to contribute to cartilage degradation 
[19, 20]. Blockage of DKK-1 with anti DKK-1 antibody 
has been shown to increase bone formation in a mouse 
model of rheumatoid arthritis [21]. Elevated serum levels 
of DKK-1 in humans has been shown to be associated with 
reduced risk of OA progression as well as reduce risk of 
joint space narrowing that consequently leads to cartilage 
degradation [4, 22]. DKK-1 suppresses chondrocyte hyper-
trophy, reduces type X collagen expression, but enhances 
ADAMTS-5 (a disintegrin and metalloproteinase with 
thrombospondin motifs) and MMP-13 (matrix metallopro-
teinase 13) expression [23, 24]. However, systemic inhibi-
tion of DKK-1 and its overexpression in chondrocytes is 
shown to diminish development of OA [25, 26].
There is little information on the role of the Wnt antago-
nist SOST in OA. Reduction in the number of SOST-pos-
itive osteocyte cells has been noted to be associated with 
increased bone density in the femoral neck of hip OA 
patients [27]. SOST expression is shown to be down-regu-
lated by mechanical loading [28] but can be up-regulated by 
pro-inflammatory cytokines [29]. Recently SOST expres-
sion in mineralized chondrocytes in human growth plate 
and in articular cartilage biopsies in patients with end-stage 
OA has been reported [30, 31]. Histologically, human knee 
chondrocytes and osteocytes in trabecular bone has been 
shown to express SOST [32]. Furthermore, SOST expres-
sion in chondrocytes has been shown to be up-regulated the 
area of cartilage damage in animal model of OA, and its 
expression was shown to be decreased in osteocytes resid-
ing in subchondral bone associated with bone sclerosis in 
those animals [32].
To date, there have been no histological studies on 
the expression of SOST and DKK-1 in human hip OA, 
although there is extensive evidence of bone remodeling 
associated with the destructive loss of cartilage. The aims 
of the current study were firstly to map the cellular distribu-
tion of these two Wnt antagonists in relation to the zones of 
maximal, partial, and no cartilage damage, as well as in the 




Human femoral head samples were collected from 4 male 
patients aged 50–55 year undergoing total hip replacement. 
Cylindrical perpendicular bone cores (6 × 10  mm2 diam-
eter) were taken longitudinally (Fig. 1); through midpoint 
of full thickness defect, margin of full thickness defect, 
through base of osteophyte, through macroscopically “nor-
mal cartilage”, fixed in 4% paraformaldehyde at 4 °C over-
night, decalcified in 0.5 M ethylenediaminetetraacetic acid 
(Lonza, UK) solution over 6 weeks and embedded in paraf-
fin wax. All cores for histological analysis were taken from 
the same position on the femoral heads relative to the full 
thickness defect or osteophyte, and the anatomical locations 
were confirmed clinically prior to cores being taken. Cores 
are not in the same plane within each specimen. Paraffin 
embedded human bone samples were cut longitudinally 
in serial sections at 5 µm and mounted on adhesive glass 
slides (Lecia Biosystems, UK). Slides were deparaffinised 
in xylene and rehydrated through a graded series of alco-
hols to water. Slides were washed with Tris-buffered saline 
and Tween 20 (TBST), and endogenous peroxidase activ-
ity was quenched with 3% hydrogen peroxide for 30 min. 
Antigen retrieval was performed on an 85 °C hot plate 
using citrate buffer for 10 min for sclerostin or 20 min in 
proteinase K (20 µg/ml) for DKK-1. Non-specific reactiv-
ity was blocked in TBST-5% bovine serum albumin (BSA) 
for 30 min at room temperature. Representative slides were 
incubated overnight at 4 °C with rabbit anti-human DKK-1 
(Sigma-Aldrich), rabbit anti-human SOST (ABGENT, 
USA) antibodies (1:200 dilution).
After primary antibody incubation reaction, appropri-
ate secondary biotinylated antibody (Vector Laboratories) 
was applied for 30  min at room temperature. Sections 
then were rinsed with TBST, and visualized using the avi-
din–biotin peroxidase diluted at 1:200 for 30 min. Sections 
were rinsed with TBST and treated with DAB (Vector labs, 
UK: 3, 3 diaminobenzidine). Sections were counterstained 
with haematoxylin or methyl green for 10 s, washed under 
running water for 30  s, dehydrated in ethanol, cleared in 
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xylene, and cover slipped with DEPEX mounting medium. 
Sections were examined using an Olympus BX40 light 
microscope, and photographs were captured at 4–×20 mag-
nifications. For general morphological analysis, decalci-
fied sections were stained with Mayer’s H&E, and negative 
control sections were incubated with 1:200 dilution of the 
non-immunized rabbit serum (R&D Systems, UK).
Statistical analysis
For quantification of histological staining, images of sub-
chondral bone surfaces were captured at ×10 magnifica-
tion from each slide, and cross-sectional areas of the sub-
chondral bone plates were measured with ImageJ software 
(µm2). Total number of positive cells were counted manu-
ally under light microscope and plotted against subchondral 
bone thickness and represented as number of positive cells 
per µm2 as mean ± SEM from 6 slides per each core from 4 
femoral head biopsies. Statistical analyses were carried out 
using SPSS version 11.0 for windows (SPSS Inc., Chicago, 
IL, USA). Subchondral bone thicknesses and number of 
positive cells per µm2 were compared by One-Way analysis 
of variance (ANOVA), using Tukey’s multiple comparison 




In an attempt to identify whether the presence or absence 
of cartilage, partial cartilage defect or presence of osteo-
phytes would affect the thickness of the subchondral plate 
the structural parameters of subchondral bone plate were 
evaluated (Fig.  1a–e). There was no significant difference 
Fig. 1  Subchondral bone thickness varies in OA femoral head. 
Cylindrical cores were taken from 4 OA femoral head biopsies. Insert 
cartoon represents the proposed taken sections of femoral head. Core 
1 macroscopically normal cartilage, Core 2 partial cartilage defect, 
Core 3 full cartilage defect, Core 4 osteophyte. Representative images 
of H&E staining from a macroscopically normal cartilage, b partial 
cartilage defect, c full cartilage defect, and d osteophyte. e Cross-sec-
tional areas of subchondral bone thickness measured by ImageJ soft-
ware (µm2). Data are presented as mean ± SEM (One-way analysis of 
variance, Tukey’s multiple comparison test) from six slides per each 
core from four femoral head biopsies. (#P < 0.05 and ###P < 0.001 
for comparison of subchondral bone between full cartilage defect in 
cores 3 and osteophytes in cores 4 with macroscopically normal carti-
lage in cores 1, **P < 0.01, and ***P < 0.001 for comparison of core 
3 to other cores). Magnifications in a–d (×4), dashed line osteophyte, 
solid line cartilage and arrowheads indicate subchondral bone. Not 
significant (ns), superior (Sup), inferior (Inf), median (Mid), and lat-
eral (Lat)
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in subchondral bone thickness in cores taken from regions 
of macroscopically normal cartilage (100%) and partial 
thickness cartilage defect (103%) (Fig. 1e, core 1 and core 
2). Subchondral bone plate was significantly thicker in 
cores taken from regions with full cartilage defect (207.2%) 
compared to cores with macroscopically normal cartilage, 
Fig. 2  DKK-1 expression 
is high in OA chondrocytes 
Cylindrical cores were taken 
from OA femoral head biopsies, 
fixed in paraformaldehyde, 
decalcified in EDTA, 5 µm 
serial sections were cut lon-
gitudinally and stained with 
anti-human DKK-1 antibody. 
a–c Representative H&E stain-
ing of cartilage in cores taken 
from macroscopically normal 
cartilage, partial cartilage, and 
osteophyte regions. DKK-1 
immunostaining only observed 
in chondrocytes in cores taken 
from macroscopically normal 
cartilage (blue arrows in d), but 
not in partial cartilage defect 
(black arrows in e) or osteo-
phyte regions (red arrows in f) 
respectively. a–c ×4, d and f 
×10 and e ×20 magnification
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partial cartilage defect and subchondral bone of cores taken 
from osteophytes (P < 0.001, Fig.  1e). Subchondral bone 
plate was thinnest in cores taken from osteophytes (27.5%) 
(P < 0.05, Fig. 1e).
When OA femoral head cores were examined for DKK-1 
immunoreactivity, surface chondrocytes in macroscopically 
normal cartilage regions (Fig.  2d, blue arrows) expressed 
abundant DKK-1. This pattern of DKK-1 expression was 
not observed in chondrocytes in cores taken from partial 
cartilage defect (Fig.  2e, black arrows) or in osteophyte 
cores (Fig. 2f), red arrows]. However, in bone tissue, stain-
ing was seen exclusively in osteocytes in subchondral bone 
plates (Fig.  3b, e). DKK-1 expression was significantly 
higher in subchondral bone of cores taken from regions 
with partial cartilage defects compared to subchondral bone 
in macroscopically normal cartilage, full cartilage defect, 
or osteophyte (P < 0.0001, Fig. 3d). It was of interest that 
osteocytes residing in trabecular bone in partial defect 
cores co-expressed both DKK-1 and SOST, the observation 
that was not evident in other cores (Fig. 4c–h).
Similar to DKK-1 expression, SOST expression in OA 
cores was exclusively in osteocytes (Fig.  5b, e) and at 
highest levels in cores taken from partial cartilage defect 
compared to macroscopically normal cartilage, full car-
tilage defect, and osteophyte cores (P < 0.001, Fig.  5d). 
SOST was not expressed in chondrocytes and no DKK-1 or 
SOST immunoreactivity was observed in osteoblasts lining 
subchondral bone plate (Figs. 3e, 5e, black arrows). Osteo-
clasts were most abundant in the bone underlying macro-
scopically normal cartilage, as evidenced by Cathepsin K 
staining (Fig. 6).
Discussion
This study has demonstrated that DKK-1 and SOST expres-
sion is highest in osteocytes underlying actively eroding 
cartilage (partial defects) and lowest under full thickness 
cartilage defects and macroscopically normal cartilage 
(Table  1). In direct contrast, subchondral bone is thickest 
underneath full thickness cartilage defects. Subchondral 
bone is known to be a very dynamic structure and adapted 
to mechanical forces that are frequently imposed across the 
joint [33]. Osteocytes are the only permanently resident 
Fig. 3  DKK-1 is over-expressed in osteocytes in subchondral bone 
underlying OA partial cartilage defect Cylindrical cores were taken 
from OA femoral head biopsies, fixed in paraformaldehyde, decal-
cified in EDTA, serial 5  µm sections were cut longitudinally and 
stained with anti-human DKK-1 antibody. a–c Representative stain-
ing of serial sections of subchondral bone of core taken from partial 
cartilage defect, a H&E staining, b  DKK-1 immunostaining, c IgG 
negative staining, d quantification of DKK-1 immunoreactive osteo-
cytes in subchondral bone from macroscopically normal cartilage 
cores (1), partial cartilage defect (2), full cartilage defect (3), and 
osteophyte (4). e High magnification of immunoreactive osteocytes 
from slide B. No immunoreactivity was observed in osteoblasts lin-
ing the subchondral bone plate (black arrows in e). a–c x10 and e x20 
magnification. Data presented as mean ± SEM (One-way analysis of 
variance, Tukey’s multiple comparison test) of positive osteocytes per 
µm2 from 6 slides per each core from 4 femoral head biopsies com-
pared to macroscopically normal cartilage. ***P < 0.001 for compari-
son of core 2 with other cores
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cells within the subchondral bone, and our data further 
elaborate that alteration in the overlying cartilage thick-
ness as a result of disease is associated with changes in Wnt 
activity.
Histological analysis of OA bone in this study has 
revealed that osteocyte cells exclusively co-express the Wnt 
inhibitors DKK-1 and SOST. It has been previously shown 
that chondrocytes in OA also express DKK-1 [23], and we 
also observed that this expression was only in the superfi-
cial layer of cartilage in our samples but not in mid or deep 
zones of cartilage. Furthermore, in our histological stud-
ies, DKK-1 was only seen in chondrocytes in cores taken 
Fig. 4  Co-expression of 
DKK-1 and SOST in OA 
trabecular bone. Representative 
staining of serial sections of 
trabecular bone in core taken 
from region of partial cartilage 
defect. a H&E staining, b IgG 
negative staining, c, e, g SOST 
immunostaining, d, f, h DKK-1 
immunostaining. a, b ×4 and 
c–f ×10, g–h ×20 magnification
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from regions with macroscopically normal cartilage, and 
no expression was seen in other cores such as partial defect, 
or osteophytes. Additionally, histological analysis of serial 
sections also revealed that chondrocytes that expressed 
DKK-1 did not express SOST, and that no expression 
of SOST was observed in any chondrocytes in any of the 
cores.
The fact that subchondral bone was thicker in full car-
tilage defects coincides with the lack or lower expression 
of both DKK-1 and SOST and suggests higher Wnt activ-
ity. The higher expression of DKK-1 and SOST in osteo-
cytes in cores taken from partial cartilage defect regions 
may reflect changes in loading as well as signaling from 
the adjacent eroding cartilage. Although we mainly focused 
on patterns of expression of these two markers in subchon-
dral bone, it is interesting to note that osteocytes residing in 
trabecular bone in partial defect cores also predominantly 
co-expressed both DKK-1 and SOST. This expression was 
completely absent in trabecular bone of other cores.
Another finding of this study was the presence of giant 
multi-nucleated osteoclasts apparently resorbing cartilage 
in cores taken from macroscopically normal cartilage 
regions. This expression was only seen where subchon-
dral bone had been invaded by bone marrow. It has been 
previously shown that osteoclasts are capable of resorb-
ing calcified cartilage [34]; however, what signals these 
osteoclasts to appear in macroscopically normal cartilage 
remains unknown.
Given the cross-sectional nature of this method, 
we were unable to determine cause from effect of the 
observed findings and OA progression. As an experi-
mental limitation, the analysis in this study represents a 
pilot work on relatively low sample number, and a larger 
cohort study could further confirm differential patterns of 
expression of Wnt antagonists in various regions of OA 
hip. In summary, we showed that subchondral bone thick-
ness changes during the pathogenesis of OA by design-
ing a method of taking cores from different regions of 
OA bone. Using this technique, we revealed that differ-
ent compartments of bone within the same sample show 
different patterns of expression of Wnt antagonists. This 
system also shows that a dynamic sequence of changes 
are evident in osteocyte cells within subchondral bone. 
Whether these changes are caused by altered mechanical 
Fig. 5  SOST is over-expressed in subchondral bone osteocytes 
underlying partial cartilage defect (a–c) Representative staining of 
serial sections of subchondral bone of cores taken from region with 
partial cartilage defect. a H&E staining, b SOST immunostaining, 
c IgG negative staining, d quantification of SOST immunoreactive 
osteocytes in subchondral bone from macroscopically normal carti-
lage (core 1), partial cartilage (core 2), full cartilage defect (core 3) 
and osteophyte (core 4). e High magnification of immunoreactive 
osteocytes from slide b. a–c ×10 and e ×20 magnification. Data pre-
sented as mean ± SEM (One-way analysis of variance, Tukey’s multi-
ple comparison test) of positive osteocytes per µm2 from 6 slides per 
each core from 4 femoral head biopsies. ***P < 0.001 for comparison 
of immunoreactive osteocytes from cores taken from partial cartilage 
defect (cores 2) to other cores
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loading and have any consequences on cartilage degrada-
tion or bone remodeling is unclear.
Without direct measurements, it is not possible to con-
firm loading but hip lesions typically develop in the same 
position, such that Core 3 will have been subjected to the 
greatest cumulative loading, and therefore, the cartilage 
lesion develops here as well as the sclerotic bone. In con-
trast Core 1 is never directly loaded in the hip. Hip OA 
patients typically adjust their stance and gait to relieve 
painful pressure. Studies on osteophyte growth suggest 
that loading is likely to be highest in the proximity of 
an osteophyte, or Core 4. This may mean that Core 2 is 
newly unloaded or less loaded, consistent with the upreg-
ulation of Wnt antagonists, or that Core 2 is under altered 
load due to the altered matrix composition in active cata-
lytic cartilage degradation, the combination of which 
drives upregulation of Wnt antagonists.
Fig. 6  Osteoclast number is high in OA macroscopically normal car-
tilage Cylindrical cores were taken from OA femoral head biopsies, 
fixed in paraformaldehyde, decalcified in EDTA, 5 µm serial sections 
were cut longitudinally, and stained with anti-human CATK antibody. 
a–c Representative staining of serial sections of cartilage in core 
taken from full thickness cartilage. a H&E staining, b IgG negative 
staining, c CATK immunostaining, d quantification of CATK posi-
tive osteoclasts (OC) in cores from full thickness cartilage (1), par-
tial cartilage (2), full cartilage defect (3) and osteophyte (4). e High 
magnification of immunoreactive osteoclasts from slide c. a and b 
×4, c ×10 and e ×20 magnification. Data presented as mean ± SEM 
(One-way analysis of variance, Tukey’s multiple comparison test) of 
positive osteoclasts from 6 slides per each core from 4 femoral head 
biopsies. ### P < 0.001 for comparison of immunoreactive osteoclasts 
from cores relative to core 1
Table 1  Immunohistochemical 
expression of DKK-1, SOST 
and osteoclast number in OA 
cores





Full cartilage defect Osteophyte
Cartilage depth ++++ ++  - n/a
Subchondral bone depth ++ ++ ++++ +
DKK-1 +  ++++ ++ ++
SOST + ++++ + +
Osteoclast number ++++ +  + +
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Conclusions
This study is the first to demonstrate that osteocytes in 
subchondral bone co-express two inhibitors of the Wnt 
signaling pathway. The current study suggests a role for 
osteocytes in the structure and pathological remodeling 
of subchondral bone. It is of interest to find out what the 
effects of these inhibitors would be on other cells in OA 
bone such as osteoclasts. Further studies on the role of 
osteocytes in subchondral bone in OA may ultimately pro-
vide therapeutic targets for treatments of OA.
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